Literature DB >> 3926889

Regulation of IFN-gamma induction in human peripheral blood cells by exogenous and endogenously produced interleukin 2.

J Vilcek, D Henriksen-Destefano, D Siegel, A Klion, R J Robb, J Le.   

Abstract

Interferon (IFN)-gamma production, stimulated by the addition of exogenous interleukin (IL) 2, T cell mitogens, or tuberculin purified protein derivative (PPD) was studied in cultures of separated human mononuclear cells or unseparated peripheral blood leukocytes (PBL). IFN-gamma was induced by the addition of IL 2 to cultures of otherwise unstimulated cells. The minimal concentration of exogenous IL 2 required to cause a reproducible stimulation of IFN-gamma was about 10 U/ml, i.e., approximately 50 times the minimal concentration required to stimulate proliferation in an IL 2-dependent murine cytotoxic T cell line. Approximately 500 to 1000 IL 2 U/ml were required to produce maximal stimulation of IFN-gamma production in otherwise unstimulated cultures. Monoclonal antibody anti-Tac, specific for an epitope associated with the IL 2 receptor (IL 2 R), inhibited IFN-gamma induction by exogenous IL 2 less strongly than induction by phytohemagglutinin (PHA) or concanavalin A (Con A). The highest degree of inhibition was exerted by anti-Tac on IFN-gamma production stimulated with PPD. Stimulation of IFN-gamma induction by exogenous IL 2 and the inhibitory action of anti-Tac on IFN-gamma production were also seen in cultures of irradiated (2000 R) cells. Treatment of cells with subinducing doses of Con A or phorbol myristate acetate increased IFN-gamma induction by exogenous IL 2. Taken together, the data suggest that endogenously generated IL 2 is a major mediator of IFN-gamma induction in PBL cultures stimulated with antigens or T cell mitogens.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3926889

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  24 in total

1.  Involvement of gamma interferon in antibody enhancement by adjuvants.

Authors:  M J Odean; C M Frane; M Van derVieren; M A Tomai; A G Johnson
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.441

Review 2.  Polypeptides controlling hematopoietic cell development and activation. I. In vitro results.

Authors:  F Herrmann; R Mertelsmann
Journal:  Blut       Date:  1989-03

3.  Loci controlling lymphocyte production of interferon c after alloantigen stimulation in vitro and their co-localization with genes controlling lymphocyte infiltration of tumors and tumor susceptibility.

Authors:  Marie Lipoldová; Helena Havelková; Jana Badalova; Jarmila Vojtísková; Lei Quan; Magdaléna Krulova; Yahya Sohrabi; Alphons P Stassen; Peter Demant
Journal:  Cancer Immunol Immunother       Date:  2010-02       Impact factor: 6.968

4.  Evidence that defective interferon-gamma production in atopic dermatitis patients is due to intrinsic abnormalities.

Authors:  U Reinhold; W Wehrmann; S Kukel; H W Kreysel
Journal:  Clin Exp Immunol       Date:  1990-03       Impact factor: 4.330

5.  Antigen-stimulated human interferon-gamma generation: role of accessory cells and their expressed or secreted products.

Authors:  C D Kelly; C M Russo; B Y Rubin; H W Murray
Journal:  Clin Exp Immunol       Date:  1989-09       Impact factor: 4.330

6.  Characterization of cytokine gene expression in CD4+ and CD8+ T cells after activation with phorbol myristate acetate and phytohaemagglutinin.

Authors:  J C Leung; C K Lai; Y L Chui; R T Ho; C H Chan; K N Lai
Journal:  Clin Exp Immunol       Date:  1992-10       Impact factor: 4.330

7.  IL-4 acts as a homeostatic regulator of IL-2-induced TNF and IFN-gamma.

Authors:  C Bello-Fernandez; P Oblakowski; A Meager; A S Duncombe; D M Rill; A V Hoffbrand; M K Brenner
Journal:  Immunology       Date:  1991-02       Impact factor: 7.397

8.  High frequency of spontaneous interferon-gamma-producing cells in human tonsils: role of local accessory cells and soluble factors.

Authors:  M Quiding; G Granström; I Nordström; B Ferrua; J Holmgren; C Czerkinsky
Journal:  Clin Exp Immunol       Date:  1993-01       Impact factor: 4.330

9.  T-cell subpopulations, expression of interleukin-2 receptor, and production of interleukin-2 and gamma interferon in human American cutaneous leishmaniasis.

Authors:  M Castes; M Cabrera; D Trujillo; J Convit
Journal:  J Clin Microbiol       Date:  1988-06       Impact factor: 5.948

10.  Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3. Specific inhibition at the level of messenger RNA.

Authors:  W F Rigby; S Denome; M W Fanger
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.